california dmhc glp-1 coverage exclusion allowed medi-cal to stop covering weight loss drugs GLP-1 CARVE OUTS AND MENTAL
Description
Molecular Metabolism, 3, 507517
A licensed provider in the patient's state then reviews the submitted information and determines whether GLP-1 treatment is medically appropriate
26,27 The rate of gastric emptying is particularly relevant as it is a major determinant of post-meal glucose levels in people with and without diabetes and may, hence, influence treatment regimens
Hwang YJ, Kim N, Yun CY, Yoon H, Shin CM, Park YS, et al
508511 Additionally, GLP-1 mitigates liver inflammation and fibrosis by inhibiting the NF-B pathway, reducing the release of pro-inflammatory cytokines such as TNF- and IL-6, and thus suppressing inflammatory pathways
It means people should be careful and talk with a healthcare provider
